Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drugBREISTØL, K; HENDRIKS, H. R; FODSTAD, Ø et al.European journal of cancer (1990). 1999, Vol 35, Num 7, pp 1143-1149, issn 0959-8049Article

Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft modelsBREISTØL, K; BALZARINI, J; SANDVOLD, M. L et al.Cancer research (Baltimore). 1999, Vol 59, Num 12, pp 2944-2949, issn 0008-5472Article

Nude rat models for human tumor metastasis to CNS: procedures for intracarotid delivery of cancer cells and drugsMYKLEBUST, A. T; HELSETH, A; BREISTØL, K et al.Journal of neuro-oncology. 1994, Vol 21, Num 3, pp 215-224, issn 0167-594XArticle

The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenograftsBREISTØL, K; HENDRIKS, H. R; BERGER, D. P et al.European journal of cancer (1990). 1998, Vol 34, Num 10, pp 1602-1606, issn 0959-8049Conference Paper

A study of the delivery-targeting concept applied to antineoplasic drugs active on human osteosarcoma. I: Synthesis and biological activity in nude mice carrying human osteosarcoma xenografts of gem-bisphosphonic methotrexate analoguesSTURTZ, G; APPERE, G; BREISTOL, K et al.European journal of medicinal chemistry. 1992, Vol 27, Num 8, pp 825-833, issn 0223-5234Article